Mesalamine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 42291-489
  • Package NDC 42291-489-18
  • Application number ANDA213191
  • SPL ID 485f7bde-a4c9-b05b-e063-6394a90a34cf
  • SPL set ID 22f3ee49-ac57-84f5-e063-6394a90aae91
  • UNII 4Q81I59GXC
  • RxCUI 833234

What the source publishes

Labeler
AvKARE
Active ingredients
Mesalamine
Form
TABLET, DELAYED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:42291-489_485f7bde-a4c9-b05b-e063-6394a90a34cf
{
  "name": "Mesalamine",
  "splId": "485f7bde-a4c9-b05b-e063-6394a90a34cf",
  "labels": [
    {
      "setId": "22f3ee49-ac57-84f5-e063-6394a90aae91",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22f3ee49-ac57-84f5-e063-6394a90aae91",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22f3ee49-ac57-84f5-e063-6394a90aae91"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AvKARE",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "180 TABLET, DELAYED RELEASE in 1 BOTTLE (42291-489-18)",
      "package_ndc": "42291-489-18",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240925"
    }
  ],
  "productId": "42291-489_485f7bde-a4c9-b05b-e063-6394a90a34cf",
  "useDomain": "unknown",
  "dosageForm": "TABLET, DELAYED RELEASE",
  "productNdc": "42291-489",
  "deaSchedule": null,
  "genericName": "Mesalamine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "MESALAMINE",
      "strength": "800 mg/1"
    }
  ],
  "applicationNumber": "ANDA213191",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240925",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175781",
      "M0000971"
    ],
    "unii": [
      "4Q81I59GXC"
    ],
    "rxcui": [
      "833234"
    ],
    "spl_set_id": [
      "22f3ee49-ac57-84f5-e063-6394a90aae91"
    ],
    "pharm_class_cs": [
      "Aminosalicylic Acids [CS]"
    ],
    "pharm_class_epc": [
      "Aminosalicylate [EPC]"
    ],
    "manufacturer_name": [
      "AvKARE"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:42291-489_485f7bde-a4c9-b05b-e063-6394a90a34cf"